Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > LATEST
LATEST
-
REGULATORY Japan Health Minister Says Early Call on FY2027 Off-Year Revision Improves Predictability
January 22, 2026
-
REGULATORY Japan Grants Sakigake Tag to Nanoscope’s MOGENRY
January 22, 2026
-
BUSINESS Otsuka/Ionis’ HAE Drug Dawnzera Approved in Europe
January 22, 2026
-
REGULATORY MHLW Official Making Rounds to Rally Private Support for Drug Discovery Fund
January 21, 2026
-
BUSINESS Shionogi to Lift Stake in ViiV to 21.7% as Pfizer Exits
January 21, 2026
-
ORGANIZATION Kobe, iPark Institute, Partners Sign Pact to Accelerate Innovation at KBIC
January 21, 2026
-
REGULATORY Cabinet OKs Subsidy to Boost Antibiotic API Stockpiles, Allocates 7.1 Billion Yen from Reserve
January 21, 2026
-
BUSINESS Fuji Pharma Earns Approval for High-Dose Stelara Biosimilar
January 21, 2026
-
REGULATORY PMDA Chief Vows Stronger Support for Drug Discovery, Orphan Designations
January 21, 2026
-
ORGANIZATION OTC Industry Head Urges Caution on Extra Charges for “OTC-Like” Drugs
January 20, 2026
-
REGULATORY AMED, JPMA Poised to Embed Pharma Expertise in Drug Discovery
January 20, 2026
-
REGULATORY Japan’s Lower House Poll Set for Feb. 8 after Takaichi Calls Snap Vote
January 20, 2026
-
REGULATORY Daiichi, University of Tokyo Professor Win Japan’s PM Award for Ezharmia Development
January 20, 2026
-
ORGANIZATION JETRO Picks 10 Overseas Startups for Regenerative Medicine Japan Entry Program
January 20, 2026
-
BUSINESS Kaken’s Hyperhidrosis Drug Ecclock Now Available in South Korea
January 20, 2026
-
BUSINESS Daridorexant Hits Primary Goal in South Korea PIII Insomnia Trial, Nxera Plans Filing in Q1 2026
January 20, 2026
-
BUSINESS Enhertu Combo Accepted for EU Review in First-Line HER2 Breast Cancer
January 20, 2026
-
REGULATORY Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead
January 19, 2026
-
REGULATORY Chuikyo OKs 3.5% Minimum NHI Price Hike, Sets Grace Period for New AG Pricing
January 19, 2026
-
BUSINESS Oncolys Aims for First-Line Use of Telomelysin in Esophageal Cancer
January 19, 2026
ページ
As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…